bibliographic entry 10166866 [be/10166866]
https://w3id.org/oc/corpus/be/10166866

is a

• bibliographic reference

content

• Degn KB, Juhl CB, Sturis J et al. One week's treatment with the long‐acting glucagon‐like peptide 1 derivative liraglutide (NN2211) markedly improves 24‐h glycemia and alpha‐ and beta‐cell function and reduces endogenous glucose release in patients with type 2 diabetes. Diabetes 2004; 53: 1187–1194. PMID: 15111485

references

• https://w3id.org/oc/corpus/br/3491319